12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women

NCT ID: NCT04014686

Last Updated: 2020-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-01

Study Completion Date

2018-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to examine the impacts of a 12-week resistance band exercise program on insulin resistance, blood lipid profiles, body composition, and blood pressure in postmenopausal women with obesity.

Thirty-six postmenopausal women participated in this study. Participants were randomly allocated into the resistance band training group (EX, n = 18) or the control group (CON, n = 18). The EX group performed a resistance band exercise training program 60 minutes per day, 3 times per week, for 12 weeks. The CON group did not participate in any exercise, dietary, or behavioral intervention. Blood glucose, insulin, homeostatic model of insulin resistance (HOMA-IR), blood lipids, blood pressure, and body composition were measured before and after 12 weeks of EX or CON.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Dyslipidemias Insulin Resistance Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

exercise intervention group, control group
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

No exercise intervention

Group Type SHAM_COMPARATOR

No exercise intervention group

Intervention Type OTHER

no exercise intervention

Exercise intervention group

Exercise intervention group (resistance band exercise training for 12 weeks, 3x per week, for 60 minutes per day).

Group Type EXPERIMENTAL

Resistance band exercise intervention group

Intervention Type BEHAVIORAL

Resistance band exercise training intervention (12 weeks, 3x per week, for 60 minutes per day)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No exercise intervention group

no exercise intervention

Intervention Type OTHER

Resistance band exercise intervention group

Resistance band exercise training intervention (12 weeks, 3x per week, for 60 minutes per day)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* postmenopausal (cessation of menses for at least 12 consecutive months)
* abdominal obesity (waist \> 80 cm)

Exclusion Criteria

* current smoker (smoking within 6 months of participation)
* cardiovascular disease
* renal disease
* pulmonary disease
* thyroid disease
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dong-Eui University

OTHER

Sponsor Role collaborator

University of Nebraska

OTHER

Sponsor Role collaborator

Pusan National University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Won-mok son

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Nebraska at Omaha

Omaha, Nebraska, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UNOmaha9

Identifier Type: -

Identifier Source: org_study_id